Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1994-03-18
1997-10-07
Ceperley, Mary E.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435960, 436 63, 436 64, 436519, G01N 33574, G01N 33554
Patent
active
056746938
ABSTRACT:
Derivatives of 2-nitro-imidazole, such as 1-(2-hydroxy-3-piperidinopropyl)-2-nitro-imidazole, are useful as hypoxic cell markers for immunochemical detection of hypoxia in tumor tissue.
REFERENCES:
patent: 4241060 (1980-12-01), Smithen
patent: 4282232 (1981-08-01), Agrawal
patent: 4797397 (1989-01-01), Suto et al.
patent: 5086068 (1992-02-01), Raleigh et al.
C. E. Smithen et al., Radiat. Sensitizers: Their Use Clin. Manage. Cancer Novel(nitro-1-imidazolyl)-alkanolamines as potential radiosensitizers with improved therapeutic properties.
R.C. Urtasun et al., Br. J. Cancer (1986) vol. 54, pp. 453-457. (1986).
Raleigh et al., Br. J. Cancer, vol. 69, 1994, pp. 66-71. (1994).
Chapman, "Medical Intelligence", vol. 301, No. 26, pp. 1429-1432. (1979).
Raleigh et al., Br. J. Cancer, vol. 56, 1987, pp. 395-200. (1987).
Lee David Yue-wei
Raleigh James Arthur
Ceperley Mary E.
Natural Pharmacia International Inc.
LandOfFree
Derivatives of 2-nitro-imidazoles as hypoxic cell markers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of 2-nitro-imidazoles as hypoxic cell markers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of 2-nitro-imidazoles as hypoxic cell markers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2356042